XML 74 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation Plans
9 Months Ended
Jun. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Plans

(7) Stock-Based Compensation Plans. As more fully described in Note 7 to the Company’s notes to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended September 30, 2012, the Company’s stock-based compensation plan permits the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock units, and stock awards. The number of common shares available for future issuance was 537,880 at June 30, 2013.

 

The Company recorded the following stock compensation expense in its consolidated statements of income (in thousands):

 

    Three Months ended   Nine Months ended
    June 30,   June 30,
    2013   2012   2013   2012
Stock option grants   $ 86       86       305       313  
Annual director stock award     —         —         507       320  
    $ 86       86       812       633  

 

A summary of changes in outstanding options is presented below (in thousands, except share and per share amounts):

 

            Weighted       Weighted       Weighted  
    Number       Average       Average       Average  
    of       Exercise       Remaining       Grant Date  
Options   Shares       Price       Term (yrs)       Fair Value  
                               
Outstanding at                              
 October 1, 2012   481,210     $ 17.52       3.8     $ 3,782  
  Granted   46,180     $ 26.20             $ 489  
  Exercised   100,800     $ 10.61             $ 542  
Outstanding at                              
 June 30, 2013   426,590     $ 20.10       4.3     $ 3,729  
Exercisable at                              
 June 30, 2013   338,078     $ 18.63       3.3     $ 2,769  
Vested during                              
 nine months ended                              
 June 30, 2013   28,112                     $ 275  

 

The aggregate intrinsic value of exercisable in-the-money options was $3,897,000 and the aggregate intrinsic value of all outstanding in-the-money options was $4,300,000 based on the market closing price of $30.04 on June 28, 2013 less exercise prices. Gains of $1,577,000 were realized by option holders during the nine months ended June 30, 2013. The realized tax benefit from options exercised for the nine months ended June 30, 2013 was $610,000. Total compensation cost of options granted but not yet vested as of June 30, 2013 was $781,000, which is expected to be recognized over a weighted-average period of 3.4 years.